Abstract
Thus far, ultrasound, CT, and 2D cine phase-contrast MRI has been adopted to evaluate blood flow and vascular morphology in the portal venous system; however, all these techniques have some shortcomings, such as limited field of view and difficulty in accurately evaluating blood flow. A new imaging technique, namely 3D cine phase-contrast (4D Flow) MRI, can acquire blood flow data of the entire abdomen at once and in a time-resolved manner, allowing visual, quantitative, and comprehensive assessment of blood flow in the portal venous system. In addition, a retrospective blood flow analysis, i.e., "retrospective flowmetry," is possible. Although the development of 4D Flow MRI for the portal system has been delayed compared to that for the arterial system owing to the lower flow velocity of the portal venous system and the presence of respiratory artifacts, several useful reports have recently been published as the technology has advanced. In the first part of this narrative review article, technical considerations of image acquisition and analysis methods of 4D Flow MRI for the portal venous system and the validations of their results are described. In the second part, the current clinical application of 4D Flow MRI for the portal venous system is reviewed.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
3D cine phase-contrast (4D Flow) MRI is a new technique that allows comprehensive and retrospective assessments of whole spatio-temporal velocity vectors within the field of view (FOV) [1, 2]. Many studies and clinical applications have already been reported for the heart and aortic regions [3, 4]; however, studies on the portal venous (PV) area are hampered by its complex dual blood supply, respiratory movements, and lower flow velocity. Nevertheless, recent technological innovations [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26] have facilitated sporadic, if not comprehensive, reports in this sector. This narrative review article discusses the technical and clinical aspects of 4D Flow MRI in the portal system.
Conventional imaging tools for portal flowmetry
Doppler ultrasonography (US) remains the first choice for evaluating blood flow in the PV system under many conditions [27,28,29,30]. It allows portal flow assessments, including velocity and flow direction. Although US is a low-cost and convenient technique, it has several drawbacks [5,6,7,8,9, 20,21,22, 28,29,30,31,32], such as relatively poor reproducibility, narrow FOV, and limited ability to depict complex structures. Moreover, its image quality is degraded by gases in the gastrointestinal tract and by subcutaneous and organ fat in obese individuals.
Conventional MR flowmetry includes 2D cine phase-contrast (PC) MRI [9, 32,33,34,35,36]. Although 2D cine PC is superior to 4D Flow MRI in terms of temporal and in-plane resolution, a flow measurement plane must be prescribed during MR imaging [8, 21, 36], which is cumbersome and requires operators to have a detailed anatomical understanding. Unlike conventional 2D cine PC or US, 4D Flow MRI can retrieve whole spatio-temporal velocity data en bloc; therefore, retrospective and comprehensive analyses are possible even after patients leave the MR suite.
Dynamic contrast-enhanced (DCE) CT can robustly assess the vascular geometry because it is acquired during a single breath hold, provides high-resolution images, and allows comprehensive morphological analyses [37]. However, its capabilities in flow analysis are limited. Contrast administration is almost compulsory; therefore, patients with allergies or renal dysfunction are not indicated. In addition, CT is not free from radiation exposure [7, 17].
Angiography is relatively invasive, requires contrast media, and involves ionizing radiation; it is no longer used for testing alone except for concurrent interventional procedures [37].
Technical considerations of 4D Flow MRI in the portal system
Data acquisition
In 4D Flow MRI, bipolar velocity-encoded gradients are added in three directions (x, y, and z) to obtain three-dimensional velocity vector data (Fig. 1). Protons moving along each axis accumulate a phase shift relative to the stationary protons. The phase shift during a time period corresponds to the velocity, which is displayed as the signal intensity on the phase images.
For row data or k-space trajectories, there are two types of sampling, i.e., Cartesian sampling [5, 7, 10, 23,24,25,26] and non-Cartesian sampling. Traditional Cartesian sampling requires around 15–30 min for imaging in the body, whereas further use of cutting-edge techniques allows single-breath-hold acquisition in around 22 s [12, 14]. Non-Cartesian sampling aims to image a larger area in a shorter time and with a higher spatial resolution, and it has been reported for radial [6, 8, 11, 13, 20] and spiral [12, 14] undersampling accelerated acquisition methods. To further reduce the imaging time, methods such as parallel imaging, compressed sensing, and k-t acceleration are often used together [12, 21,22,23,24,25, 38].
Data acquisitions of 4D Flow MRI are synchronized to the cardiac cycle using an electrocardiogram (ECG) or peripheral pulse wave. The two main methods of synchronization are prospective gating [5, 7, 9, 26], in which the imaging begins when the R wave is detected, and retrospective gating [6, 8, 13, 23,24,25], in which the data are collected continuously, independently of the R wave, and reordered after data completion. Retrospective gating is useful in cases where the R–R intervals are unstable, and the imaging time can be shortened by reducing the amount of data rejected. The Society for Cardiovascular Magnetic Resonance recommends retrospective gating [38]. In the PV area, the number of time frames during one cardiac cycle is often around 10–15 frames/R–R interval [6, 8, 11, 16, 23,24,25, 39], which is lower than that in the arterial system, because little pulsation occurs in the portal system. Given the lack of pulsation, it may also be reasonable to collect and evaluate time-averaged images without time-resolving if only the portal system is to be evaluated. Landgraf et al. reported that time-averaged reconstruction allows imaging within 3–4 min and yields significantly better results in terms of portal flow measurement accuracy, average streamline length, and visualization quality compared to time-resolved reconstruction [13]. However, time-averaged reconstruction cannot simultaneously evaluate arteries and veins in the vicinity of the PV area and may experience difficulty in reflecting fluctuations due to respiration (Fig. 10).
Adapting a respiratory synchronization program may benefit abdominal imaging. 4D Flow MRI uses navigator echo techniques [5,6,7,8,9, 11, 13, 19,20,21, 23,24,25,26] that place the navigator at the liver–lung interface or the splenic–lung interface, often with a 4–7 mm end-expiratory acceptance window for data acquisition. Spiral trajectories can be imaged with a single breath hold and do not require respiratory gating [12, 14]; however, only blood flow under breath hold can be analyzed, and hemodynamic differences from free breathing must be considered [32, 40,41,42]. A recently reported self-navigation method collects data from all respiratory phases, allowing imaging in a shorter time regardless of the patient's respiratory status [43].
Maintaining a high signal-to-noise ratio (SNR) is also essential for accurate velocity measurements in 4D Flow MRI. The facilitated method uses the appropriate velocity encoding (VENC) settings and gadolinium contrast agents, which increases the image quality and analytical parameter accuracy [3, 44]. The use of non-specific extracellular contrast agents has been reported in many cases [6, 8, 11,12,13, 19, 21, 23,24,25, 39], while the use of hepatocellular-specific contrast agents has also been reported [12]. Post-contrast MR angiography (MRA), e.g., 3D fast spoiled gradient echo-based sequence, as a morphological imaging technique, provides defined vessel wall boundaries, resulting in more accurate segmentation and blood flowmetry [3, 23,24,25]. For non-contrast morphological images that are to be imaged separately, the use of a flow-sensitive technique, i.e., 3D balanced steady-state free precession imaging, has been reported [24]. Although 3D PC angiography using velocity data or magnitude data is inferior in terms of image quality, it does not require separate morphological imaging, which reduces the examination time and prevents misalignment with the blood flow signal [6,7,8,9, 11, 13, 14, 20].
Optimization of the VENC is essential for accurate blood flow assessment [2]. To enhance the SNR, the VENC should be set to the smallest value that does not exceed the maximum flow velocity of the target vessel. For regions where the flow velocity is higher than the VENC, velocity aliasing occurs, and accurate velocity evaluation becomes difficult (Fig. 2) [2]. Previous reports on normal PV evaluation have shown favorable analytical results with VENC settings of 30–60 cm/s [5, 6, 12, 13, 21]. However, higher VENC settings are necessary in the case of a stenosis because of the increased flow velocity [17, 19, 20, 25]. Higher VENC settings are also required if the arterial and transjugular intrahepatic portosystemic shunt (TIPS) pathways are to be evaluated, in which case the accuracy of the low-flow portal and venous flow parameters is reduced. Another method for optimizing the VENC is to estimate the maximum flow velocity by performing a brief 2D cine PC MRI before 4D Flow MRI. We make it a rule to determine the VENC for 4D Flow MRI by adding 20% to the measured maximum velocity as a safety margin [2, 23, 24, 45].
Dietary intake increases blood flow from the intestinal tract via the superior mesenteric vein (SMV). Therefore, it is conducive to portal blood flow measurements [11, 16, 46]. Previous reports have shown that the time between dietary intake and examination and the dietary content (e.g., fat-rich meals tend to increase blood flow more than carbohydrate-rich meals) affect the portal venous flow [46]. Therefore, 4D Flow MRI is often performed with fasting to exclude the influence of meals. However, the duration of fasting in previous reports has not been consistent, ranging from 2 to 6 h [8, 11, 12, 14, 16, 23,24,25,26]. In addition to dietary effects, some herbal medicines increase intestinal blood flow [47].
Data analysis and visualization
Segmentation of the blood vessels for analysis is performed from the acquired morphological image data. In many previous studies, 3D PC MRA was conducted using phase images and subsequently adopted as morphological images for segmentation [5,6,7,8,9, 11, 13, 14, 16, 18, 26]. However, 3D PC MRA depends on the velocity vector distribution in the vessel in 4D Flow MRI, which often results in unsatisfactory image quality compared to imaging the vessel morphology in a separate sequence. Therefore, we perform MRA separately as described above. Unlike arteries, segmentation of the PV area and veins has the following disadvantages: evaluation based on the signal value threshold is complex and the operator's subjectivity affects the detection of the vessels and contours to some extent. Thus, the size and morphology of the vessels may be inconsistent among researchers. The errors that occur here may affect the flow rate. Therefore, it is important to perform evaluations with the same criteria and pay attention to the variations among researchers. Segmentation of morphological images using artificial intelligence (AI) technology has been reported for the aorta [48], and future adaptations are expected for the PV area.
The post-processed velocity vectors can be displayed on the 3D image, and the overall blood flow can be evaluated using streamlines and 3D vector fields (Fig. 3A and B). This technique is essential for identifying the directions and velocities of the blood flow in the PV area (i.e., hepatopetal or hepatofugal with quantified blood volume). Streamlines are defined as lines connecting tandem velocity vectors [2], which allow visual evaluation of the laminar, helical, and vortical flow and flow velocities by color encoding (Fig. 4A). Helical flow is defined as an antegrade spiral, corkscrew-like motion of blood, whereas vortical flow is defined as a motion of blood that exhibits flow with a direction of rotation that deviates by more than 90 degrees from the physiological flow direction [49]. In addition, selecting arbitrary vessel cross sections and creating a 3D particle trace image, defined as virtual particles tracing the measured three-directional velocities over the cardiac cycle, allows visualization and evaluation of complex blood flows (Fig. 5 and Movie 1) [5, 7, 9].
Selecting arbitrary vessel cross sections for blood flow analysis allows the display of time-phase-specific flow velocity vectors on those vessel cross sections (Fig. 6). At this time, any misalignment between the vessel geometry and the flow velocity vectors is corrected for each cross section. The area, maximum and average flow velocity, and flow rate of an arbitrary cross section can be measured. In “retrospective flowmetry,” accurate measurement is possible by visually avoiding non-laminar flow areas (Fig. 4B), which is an advantage of 4D Flow MRI over Doppler US and 2D cine PC MRI [50, 51]. Other blood flow parameters that can be evaluated include helicity and vorticity values, which indicate vortex strength, energy loss values, and wall shear stress (WSS) and oscillatory shear index (OSI) values, which provide information on blood flow around the vessel wall (Fig. 3C and D). WSS is defined as the derivative of the fluid viscosity and the shear rate near the vessel wall. OSI reflects the temporal variation in WSS and is calculated using the temporal variation in the local WSS vector. The association of WSS and OSI parameters with vascular lesions has been shown for the aorta [3, 4] and cerebral arteries [52, 53], and these changes have been reported to be associated with atherosclerosis and aneurysm formation. However, no studies have evaluated these aspects in the PV area or abdominal veins, and their usefulness is yet to be fully explored.
Validation of 4D Flow MRI
Validation of the blood flow data generated by 4D Flow MRI in terms of reproducibility has been reported [54]. In the portal system, assurance compared to US and 2D cine PC MRI has been studied, and high concordance rates have been reported [5, 7, 10, 14, 26]. However, 4D Flow MRI tends to show lower flow velocities than Doppler US, which is attributed to averaging and partial volume effects due to lower temporal and spatial resolution than US, and to the fact that the data are composed of multiple cardiac cycles. Frydrychowics et al. compared portal blood flow on 4D Flow MRI with radial sampling and open perivascular US in pigs and showed that the measurements are in good agreement [39]. We also compared 4D Flow MRI and ultrasound flowmeter measurements in portal vein-assumed steady flow using a straight phantom and found that the measurement error was small [23]. In addition, several studies have evaluated internal consistency as an indirect validation. There are two methods. The first method is to measure multiple locations in the main PV area and evaluate the agreement of the flow rates; Roldan-Alzate et al. evaluated the flow rates at three locations in the main PV area and reported a high agreement rate of 4.2% ± 3.9% for the average absolute error [8]. The second method is to evaluate the degree of flow coincidence before and after the vascular bifurcation, as expressed by the following equation [8, 9, 11, 13]:
High concordance rates have also been demonstrated in this regard. For example, Roldan-Alzate et al. reported that the error of QSV+QSMV for QPV was 5.9 ± 2.5%, showing an excellent correlation (r2 = 0.99), and the error of QRPV+QLPV for QPV was 5.8 ± 3.1%, also showing an excellent correlation (r2 = 0.99). The interobserver and intraobserver variabilities have also been evaluated, and both have indicated very low bias (interobserver bias, 3%; intraobserver bias, 1%) [8, 11, 43]. The test–retest reproducibility, where the same subject is consecutively imaged to evaluate the reproducibility, has also been studied, and good results have been reported for large vessels [9, 12].
Limitations and future prospects of 4D Flow MRI
4D Flow MRI has several drawbacks with regard to the portal region. First, although several accelerated imaging methods have been adapted for 4D Flow MRI, the imaging requires a relatively long time in many cases. This is because the imaging requires electrocardiogram gating, respiratory gating, and a large FOV. Furthermore, combining the positioning and morphological imaging, a single session often requires around 1 h [14, 23, 24]. This makes the examination difficult for patients in poor condition or those who have difficulty lying in bed for a long time, and also makes scheduling MRI rooms more difficult. However, the imaging time has been reduced considerably by using accelerated imaging methods, and further acceleration can be expected with advances in equipment and sequences [55]. Second, the spatial resolution remains insufficient. Recent reports on the portal system have shown a near iso-voxel size of around 1.2–1.5 mm [6, 8, 11, 13, 23,24,25], with a lower spatial resolution than 2D cine PC MRI. A low spatial resolution is reported to cause a partial volume effect, and a low temporal resolution is reported to cause a smoothing effect of the flow waveform, resulting in poor blood flow evaluation [9]. Third, although the contrast media increase the SNR and yield good results when assessing small or tortuous vessels, they cannot be used in the case of renal dysfunction or allergy. Recipients in the early post-transplant period and patients with cirrhosis may have systemic edema, and non-contrast MRI may not provide adequate image quality; therefore, contrast media would be recommended whenever possible, but this is not always possible, as many such patients exhibit hepatorenal syndrome. Fourth, image analysis after imaging requires at least 1–3 h as well as human resources. As reported for the aortic region [48, 56], AI-based segmentation and analysis are expected to be applied to the PV region to reduce the analysis time and make the results uniform by eliminating human variability [55].
Clinical considerations in 4D Flow MRI for the portal system
Cirrhosis and portal hypertension: pathophysiology and comparison with healthy subjects
Early investigations of 4D Flow MRI for the portal region focused on the validation of imaging methods using healthy subjects and cirrhotic patients (Table 1) [5,6,7,8, 10,11,12,13]. Although reports of flow rates in the main PV area using 4D Flow MRI have varied from an average of 10.92 to 18.83 mL/s in healthy subjects [8, 11, 13, 43], they are comparable to those reported previously using 2D cine PC MRI and Doppler US [35, 57,58,59,60]. The progressive distortion of the architecture owing to fibrosis and regenerative nodules in the liver with chronic hepatitis and cirrhosis increases the vascular resistance at the sinusoidal level [61,62,63]. In response, a vasodilator is released to maintain hepatic blood flow, which causes systemic hypotension. This results in a compensatory increase in cardiac output, “a hyperdynamic state,” which in turn increases the portal venous pressure, as the primarily increased splenic venous blood flow further increases the portal venous blood flow [7, 64, 65]. This is accompanied by the development of hepatofugal collateral blood flow [5, 6]. As cirrhosis progresses, the intrahepatic portal branches become narrow, and the blood flow in the PV area is reduced [34]. However, in the case of severe dilatation of the paraumbilical vein, the blood flow in the main PV is increased [5]. 4D Flow MRI can evaluate the morphology, flow direction, and flow rate of these intrahepatic and extrahepatic PV areas and major collateral blood vessels all at once, providing a comprehensive assessment of the hemodynamic changes in each patient [5,6,7]. In a 4D Flow MRI study comparing healthy subjects, cirrhotic patients showed a hyperdynamic state, with high variability of the portal blood flow among patients, a predominant increase in the vascular area and flow volume of the splenic vein (SV), and increased supraceliac aorta flow velocity [7, 8, 12]. These are consistent with previous studies using other modalities [60, 66]. Brunsing et al. showed that cirrhotic patients with a portosystemic shunt (PSS) had significantly higher supraceliac aorta and PV flow compared to cirrhotic patients without PSS and healthy subjects, which may also indicate the hyperdynamic state in cirrhosis with portal hypertension [43]. 4D Flow MRI can evaluate the arterial and portal regions simultaneously by setting a relatively high VENC (60–250 cm/s), and the hepatic arterial buffer response, which implies a compensatory increase in the arterial blood flow when the PV flow is reduced, can also be confirmed [6, 9, 11, 14, 43]. The response of the PV flow to meals has also been studied previously, and patients with cirrhosis have been reported to have a lower postprandial increase in the PV flow than healthy subjects [67,68,69]. Roldan-Alzate et al. performed 4D Flow MRI imaging of healthy subjects and patients with portal hypertension before and 20 min after a meal and showed that the postprandial blood flow increase in the portal system was lower overall in patients with portal hypertension than in healthy subjects [11]. They recently reported on the diurnal variation in the portal blood flow by performing multiple time-lapsed imaging [70]. No other method can simultaneously evaluate these physiological or pathological hemodynamic changes in the entire abdomen, which is the main advantage of 4D Flow MRI.
Cirrhosis and portal hypertension: risk classification for rupture of esophageal varices
In patients with cirrhosis, elevated portal venous pressure is an important prognostically relevant symptom that can lead to complications such as varices [71, 72]. Although endoscopy and angiography are adopted as prophylactic and emergency hemostatic methods for esophagogastric varices [71, 73], prior evaluation is important because the prognosis is poor after bleeding. Although several risk assessments for esophagogastric varices rupture have been proposed, endoscopy and the hepatic venous pressure gradient (HVPG) have shown better results [74,75,76,77]. Although endoscopy has the advantage of subsequent variceal treatment, few varices require treatment; the procedure causes pain, can lead to complications such as perforation, and is expensive [71, 78]. HVPG is the difference between the balloon catheterized hepatic venous wedge pressure and the free hepatic venous pressure. It is said to indicate an increased risk of variceal rupture at 12 mmHg or higher [13, 71, 75, 77]. Although catheterization provides direct measurement of the pressure, it requires specific expertise, involves some invasiveness, and is expensive, making it unsuitable for routine testing. By contrast, 4D Flow MRI allows non-invasive evaluation and is suitable for repeated evaluations. Although 4D Flow MRI cannot directly evaluate PV pressure, it can evaluate variceal morphology, flow direction, and flow rate, allowing indirect evaluation of portal hypertension [8, 13]. Motosugi et al. compared endoscopic findings of esophageal varices with 4D Flow MRI findings in patients with cirrhosis and reported azygous venous blood flow > 0.1 L/min and fractional flow change in PV < 0 (PV at hilum flow < SMV+SV flow) correlated with high-risk esophageal varices on endoscopy [21]. They reported a sensitivity of 100% and specificity of 100% when both of these findings were present, suggesting that 4D Flow MRI may be useful in assessing the risk of esophageal variceal rupture (Fig. 7). Improvement in portal hypertension with the introduction of nonselective beta blockers has also been reported [61], and visual and quantitative assessment of risk reduction is expected in the future.
Cirrhosis and portal hypertension: evaluation of blood flow and function of the TIPS pathway
Complications arising from severe portal hypertension include esophagogastric variceal bleeding, refractory ascites, and pancytopenia due to increased splenic function [71, 72]. TIPS is widely used in Europe and the USA to directly reduce portal pressure and mitigate these complications [79,80,81,82]. TIPS is a procedure that creates a new shunt between the PV area and the hepatic vein, allowing direct flow from the PV area into the systemic circulation. It can be performed quickly and safely at high-volume centers. After TIPS creation, its shunt function should be evaluated continuously; too many shunts may increase the risk of hepatic encephalopathy (HE) and too few shunts may insufficiently reduce the portal pressure, resulting in the recurrence of portal hypertensive symptoms [20, 79, 82]. Until recently, shunt function has been assessed by clinical evaluation of changes in liver function and portal hypertensive symptoms, as well as by imaging evaluation, such as venography and Doppler US [17]. Venography can measure HVPG and also allows visual evaluation using contrast media. Although it is considered the gold standard, it is invasive, expensive, and not suitable for repeated testing [17]. Doppler US is noninvasive, but it has the aforementioned drawbacks, and comprehensive evaluation is difficult. Another report showed that only 53% of cases with abnormalities noted on Doppler US were diagnosed by venography, indicating that the accuracy is not high [83]. Therefore, 4D Flow MRI has recently been used for visual and quantitative studies [17,18,19,20]. Stancovic et al. evaluated abdominal blood flow before and 4 weeks after the TIPS procedure in 11 patients with refractory ascites or variceal bleeding using Cartesian 4D Flow MRI [18]. Bannas et al. also evaluated hepatic blood flow with radial 4D Flow MRI before as well as at 2 and 12 weeks post-TIPS in 7 patients [19]. These results favorably showed the hemodynamics of the TIPS pathway and visually and quantitatively demonstrated an increase in the peak velocity and flow volume of the main PV, SMV, and SV areas after the procedure. The TIPS-to-PV flow ratio, defined as the percentage of portal flow that flows through the TIPS pathway, showed that the TIPS pathway accounted for 80–90% of the portal blood flow in many favorable cases. One study using 4D Doppler US reported that an increase in the shunt fraction correlates with a decrease in the pressure gradient [84]; therefore, the TIPS-to-PV flow ratio measured by 4D Flow MRI may be useful in evaluating the function of the TIPS pathway and predicting complications [19]. Owen et al. studied the utility of 4D Flow MRI for assessing TIPS dysfunction using venography or 6-month clinical follow-up as a reference standard [20]. They reported that in cases that showed both abnormal TIPS pathway velocities (>190 cm/s or <90 cm/s) and focal turbulence in the pathway, pathological stenosis at venography was found with a sensitivity of 100% and specificity of 100%. These reports suggest that 4D Flow MRI is useful for preoperative evaluation and follow-up of the TIPS pathway because it allows evaluation of the TIPS pathway and surrounding portal venous system without US-like blind spots.
Cirrhosis and portal hypertension: Evaluation of HE and treatment efficacy
HE is a common liver disease and one of the most debilitating conditions [61, 85]. HE causes brain dysfunction, resulting in impaired consciousness, behavioral abnormalities, and movement disorders. Causes of HE include acute hepatic failure, large PSSs, and liver dysfunction due to cirrhosis. In the case of large PSSs, shunt embolization may improve HE as it prevents undetoxified ammonia and metabolites from flowing directly from the intestinal tract into the systemic circulation [86,87,88,89]. We evaluated two cases of HE with large PSS by comparing 4D Flow MRI with angiographic images and clinical findings before and after coil embolization [23]. The streamline of 4D Flow MRI could accurately depict angiographic images and blood flow upstream of the catheter placement, which could not be depicted by angiography. In the cases of HE with large PSS, most of the SMV blood flow was shunted directly into the systemic circulation instead of flowing to the liver, suggesting that it is associated with elevated serum ammonia levels and symptoms of HE. Shunt embolization changed the SMV blood flow anterogradely and hepatopetally and increased the portal venous blood flow. These were clinically consistent with lower serum ammonia levels and improved brain function. Further, we also observed a case in which 4D Flow MRI was useful in the diagnosis of recanalization of large PSS after coil embolization and in the evaluation of re-treatment (Fig. 8; unpublished data). Hence, 4D Flow MRI may be useful not only in evaluating initial embolization but also in evaluating recurrence and re-treatment. Imaging diagnosis of recanalization after coil embolization may be difficult with US or CT owing to deep lesions and metallic artifacts; therefore, 4D Flow MRI may be advantageous.
Liver transplantation: donor blood flow evaluation
Regardless of the cause of liver disease, liver transplantation is considered to treat end-stage cirrhosis [85, 90, 91]. Living-donor liver transplantation (LDLT) has recently become common owing to the global organ supply shortage [91, 92]. LDLT results in a smaller volume of liver transplanted into the recipient than deceased-donor liver transplantation and a graft-to-recipient body weight of less than 0.8% is associated with an increased risk of the small-for-size syndrome (SFSS) [91,92,93,94]. SFSS causes increased portal pressure and perfusion, hyperbilirubinemia, and increased international normalized ratio, leading to graft failure and mortality. Therefore, although transplanting as much liver parenchyma as possible into the recipient is desired, the safety of the donor must be guaranteed, which poses a dilemma. Donors are usually healthy individuals, and surgery is considered safe if more than 30–40% of the liver parenchyma remains, with an average increase in the residual liver size of 80% reported at 3 months postoperatively [93, 95]. However, the degree of postoperative liver enlargement varies among patients and is related to the patient's body size, preoperative liver size, and postoperative residual liver size. In addition, because the remaining vascular vessels are not enlarged postoperatively, the small original vessels increase vascular resistance, exacerbate presinusoidal portal hypertension, and affect the hepatic regenerative process. Therefore, hemodynamic information on the portal system prior to donor surgery is crucial. Rutkowski et al. performed virtual surgery on donor cases using 4D Flow MRI and computational fluid dynamics (CFD) to investigate whether preoperative images could predict postoperative hemodynamics [16]. They reported that by assuming the dilatation of the future residual PV branch obtained from the meal challenge to be the maximum postoperative dilatation, the postoperative blood flow prediction obtained by CFD using preoperative data approximated the actual postoperative streamlines and flow values of 4D Flow MRI. The results indicate that preoperative 4D Flow MRI and CFD may be used to predict postoperative donor hemodynamics. 4D Flow MRI can also simultaneously evaluate the hepatic arteries and veins, which may be useful for appropriate donor selection.
Liver transplantation: evaluation of recipient hemodynamics, postoperative complications, and treatment efficacy
MRI of the recipient is challenging. Preoperative massive ascites and subcutaneous edema cause RF wave attenuation and signal loss in the center of the body. Patients are admitted to an intensive care unit after surgery. It is difficult to perform 4D-Flow MRI, which requires a long imaging time, immediately owing to the limitation of their general condition. Meanwhile, accurate evaluation of tortuous portal collateral vessels and deep veins is difficult with US [96], and even if the morphology is known with CT, the blood flow and direction are difficult to assess [22]. 4D Flow MRI is a useful tool for these evaluations (Fig. 9). In the late postoperative period, the patient's general condition is more stable, allowing for safer 4D Flow MRI imaging and evaluation of vascular stenosis and the associated collateral pathway development. Lenz et al. performed noncontrast 4D Flow MRI to evaluate blood flow for esophageal variceal bleeding in a recipient with renoportal anastomosis for PV thrombosis [22]. In this case, Doppler US evaluation was difficult because of the deep location of the anastomotic vessels and collateral vessels; however, 4D Flow MRI enabled comprehensive evaluation of blood flow and contributed to the decision of the treatment strategy. We also evaluated the hemodynamic changes before and after portal stent placement in a patient with PV anastomotic stenosis and presinusoidal portal hypertension after LDLT using 4D Flow MRI [24]. 4D Flow MRI clearly showed turbulent flow distal to the PV stenosis and intrahepatic blood flow disproportion and effectively depicted improved blood flow after stent placement. In addition, the severe hepatofugal collateral flow seen before stenting was markedly reduced in internal streamlines the day after treatment, allowing early determination of the treatment efficacy, which is difficult with morphological images such as CT. No technique other than 4D Flow MRI can comprehensively evaluate the complex hemodynamics after liver transplantation. With this feature, future applications of 4D Flow MRI in evaluating pathological conditions such as SFSS are expected.
Budd–Chiari syndrome: evaluation of hemodynamics and treatment efficacy
Budd–Chiari syndrome is a syndrome of hepatic congestion and portal hypertension due to obstruction or stenosis of two or more main hepatic veins or anywhere from the inferior vena cava (IVC) to the right atrium [90, 97]. Chronic Budd–Chiari syndrome develops intrahepatic venous shunts and other collateral veins, such as paravertebral and subcutaneous veins [97, 98]. Hepatofugal collateral vessels associated with portal hypertension, such as esophagogastric varices, are also observed. Various treatments are adopted depending on the causative disease and hemodynamics; interventional radiology includes percutaneous transluminal angioplasty, stenting, and TIPS, for example [90, 97, 99, 100]. We analyzed the hemodynamics of a case of Budd–Chiari syndrome with suspected obstruction of three branches of the hepatic veins and membranous obstruction of the IVC with 4D Flow MRI in two respiratory phases (inspiratory and expiratory phases) (Fig. 10) [25]. 4D Flow MRI made it possible to evaluate the entire abdominal venous and portal system in one series of imaging. The results showed a pore in the membranous portion of the IVC that exhibited a high-flow jet, indicating that this case was not an IVC obstruction but a stenosis. Examination of the 3D pathline image in the inspiratory and expiratory phases showed hemodynamic changes associated with respiration. 4D Flow MRI allowed visual and quantitative evaluation of complex intra- and extrahepatic hemodynamics that were difficult to assess with Doppler US and CT, and contributed to changes in the treatment strategy. Further, the improvement in blood flow after balloon dilation of the IVC stenosis was also quantitatively confirmed by 4D Flow MRI. In the evaluation of venous blood flow, respiration, in addition to the cardiac cycle, has a strong effect [40]. Hence, separating the respiratory phases is expected to provide a more accurate understanding of the disease pathology. However, imaging with separate respiratory phases is still in the development stages and currently requires multiple sessions [25]; therefore, future technological innovations are expected to shorten the imaging time and enable imaging in a single session. In this regard, the self-navigation method may be effective [43]. In addition, because of the high-flow velocity in the jet portion, the dual-VENC method is considered necessary for accurate evaluation in a single session together with the slow-flowing venous stagnation portion [101].
4D Flow MRI for children
4D Flow MRI in children involves some difficulties that are not encountered in the case of adults. Because of the relatively long imaging time and physical restraints, sedation or general anesthesia may be required for younger children. In addition, because the vasculature is smaller than in adults, the vasculature that can be accurately evaluated with the current limited spatial resolution is limited to large vessels such as the main PV and SMV areas. However, 4D Flow MRI, which allows comprehensive evaluation without exposure to radiation, may be useful in many situations such as the evaluation of pathological conditions and surgical planning as well as post-treatment evaluation. Several studies have used 4D Flow MRI in the thoracic region for children, including for assessing congenital heart disease [102, 103]. For clinical application in the abdomen, Parekh et al. reported the use of a 1.5 Tesla MRI system [26]. They performed 4D Flow MRI, with general anesthesia if necessary, on 15 normal PV cases and 13 cases of surgical PV shunt creation for PV thrombosis. 4D-Flow MRI for children produced favorable 3D images with a high inter-observer agreement rate (κ = 0.67). The image quality was significantly better for children older than 10 years than for children younger than 10 years, possibly because the PV diameter is smaller in younger children [44]. They concluded that 4D Flow MRI of the portal region is feasible in children and is useful for comprehensive 3D image visualization and qualitative assessment.
Conclusion
4D Flow MRI is a new technology that allows comprehensive, retrospective, and quantitative assessments of the PV flow in normal and pathological cases. With further refinement in related technologies, 4D Flow MRI will be utilized in clinical applications for the abdomen.
References
Markl M, Chan FP, Alley MT, Wedding KL, Draney MT, Elkins CJ, Parker DW, Wicker R, Taylor CA, Herfkens RJ, Pelc NJ (2003) Time-resolved three-dimensional phase-contrast MRI. J Magn Reson Imaging 17(4):499–506. https://doi.org/10.1002/jmri.10272
Takehara Y (2020) 4D Flow when and how? Radiol Med 125(9):838–850. https://doi.org/10.1007/s11547-020-01249-0
Takehara Y, Isoda H, Takahashi M, Unno N, Shiiya N, Ushio T, Goshima S, Naganawa S, Alley M, Wakayama T, Nozaki A (2020) Abnormal flow dynamics result in low wall shear stress and high oscillatory shear index in abdominal aortic dilatation: initial in vivo assessment with 4D-flow MRI. Magn Reson Med Sci 19(3):235–246. https://doi.org/10.2463/mrms.mp.2019-0188
Takahashi K, Sekine T, Ando T, Ishii Y, Kumita S (2022) Utility of 4D flow mri in thoracic aortic diseases: a literature review of clinical applications and current evidence. Magn Reson Med Sci 21(2):327–339. https://doi.org/10.2463/mrms.rev.2021-0046
Stankovic Z, Frydrychowicz A, Csatari Z, Panther E, Deibert P, Euringer W, Kreisel W, Russe M, Bauer S, Langer M, Markl M (2010) MR-based visualization and quantification of three-dimensional flow characteristics in the portal venous system. J Magn Reson Imaging 32(2):466–475. https://doi.org/10.1002/jmri.22248
Frydrychowicz A, Landgraf BR, Niespodzany E, Verma RW, Roldan-Alzate A, Johnson KM, Wieben O, Reeder SB (2011) Four-dimensional velocity mapping of the hepatic and splanchnic vasculature with radial sampling at 3 tesla: a feasibility study in portal hypertension. J Magn Reson Imaging 34(3):577–584. https://doi.org/10.1002/jmri.22712
Stankovic Z, Csatari Z, Deibert P, Euringer W, Blanke P, Kreisel W, Abdullah Zadeh Z, Kallfass F, Langer M, Markl M (2012) Normal and altered three-dimensional portal venous hemodynamics in patients with liver cirrhosis. Radiology 262(3):862–873. https://doi.org/10.1148/radiol.11110127
Roldan-Alzate A, Frydrychowicz A, Niespodzany E, Landgraf BR, Johnson KM, Wieben O, Reeder SB (2013) In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension. J Magn Reson Imaging 37(5):1100–1108. https://doi.org/10.1002/jmri.23906
Stankovic Z, Jung B, Collins J, Russe MF, Carr J, Euringer W, Stehlin L, Csatari Z, Strohm PC, Langer M, Markl M (2014) Reproducibility study of four-dimensional flow MRI of arterial and portal venous liver hemodynamics: influence of spatio-temporal resolution. Magn Reson Med 72(2):477–484. https://doi.org/10.1002/mrm.24939
Stankovic Z, Csatari Z, Deibert P, Euringer W, Jung B, Kreisel W, Geiger J, Russe MF, Langer M, Markl M (2013) A feasibility study to evaluate splanchnic arterial and venous hemodynamics by flow-sensitive 4D MRI compared with Doppler ultrasound in patients with cirrhosis and controls. Eur J Gastroenterol Hepatol 25(6):669–675. https://doi.org/10.1097/MEG.0b013e32835e1297
Roldan-Alzate A, Frydrychowicz A, Said A, Johnson KM, Francois CJ, Wieben O, Reeder SB (2015) Impaired regulation of portal venous flow in response to a meal challenge as quantified by 4D flow MRI. J Magn Reson Imaging 42(4):1009–1017. https://doi.org/10.1002/jmri.24886
Bane O, Peti S, Wagner M, Hectors S, Dyvorne H, Markl M, Taouli B (2019) Hemodynamic measurements with an abdominal 4D flow MRI sequence with spiral sampling and compressed sensing in patients with chronic liver disease. J Magn Reson Imaging 49(4):994–1005. https://doi.org/10.1002/jmri.26305
Landgraf BR, Johnson KM, Roldan-Alzate A, Francois CJ, Wieben O, Reeder SB (2014) Effect of temporal resolution on 4D flow MRI in the portal circulation. J Magn Reson Imaging 39(4):819–826. https://doi.org/10.1002/jmri.24233
Dyvorne H, Knight-Greenfield A, Jajamovich G, Besa C, Cui Y, Stalder A, Markl M, Taouli B (2015) Abdominal 4D flow MR imaging in a breath hold: combination of spiral sampling and dynamic compressed sensing for highly accelerated acquisition. Radiology 275(1):245–254. https://doi.org/10.1148/radiol.14140973
Rutkowski DR, Medero R, Garcia FJ, Roldán-Alzate A (2019) MRI-based modeling of spleno-mesenteric confluence flow. J Biomech 88:95–103. https://doi.org/10.1016/j.jbiomech.2019.03.025
Rutkowski DR, Reeder SB, Fernandez LA, Roldán-Alzate A (2018) Surgical planning for living donor liver transplant using 4D flow MRI, computational fluid dynamics and in vitro experiments. Comput Methods Biomech Biomed Eng Imaging Vis 6(5):545–555. https://doi.org/10.1080/21681163.2017.1278619
Stankovic Z, Blanke P, Markl M (2012) Usefulness of 4D MRI flow imaging to control TIPS function. Am J Gastroenterol 107(2):327–328. https://doi.org/10.1038/ajg.2011.380
Stankovic Z, Rössle M, Euringer W, Schultheiss M, Salem R, Barker A, Carr J, Langer M, Markl M, Collins JD (2015) Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI. Eur Radiol 25(9):2634–2640. https://doi.org/10.1007/s00330-015-3663-x
Bannas P, Roldán-Alzate A, Johnson KM, Woods MA, Ozkan O, Motosugi U, Wieben O, Reeder SB, Kramer H (2016) Longitudinal monitoring of hepatic blood flow before and after TIPS by using 4D-flow MR imaging. Radiology 281(2):574–582. https://doi.org/10.1148/radiol.2016152247
Owen JW, Saad NE, Foster G, Fowler KJ (2018) The Feasibility of using volumetric phase-contrast MR imaging (4D flow) to assess for transjugular intrahepatic portosystemic shunt dysfunction. J Vasc Interv Radiol 29(12):1717–1724. https://doi.org/10.1016/j.jvir.2018.07.022
Motosugi U, Roldan-Alzate A, Bannas P, Said A, Kelly S, Zea R, Wieben O, Reeder SB (2019) Four-dimensional flow MRI as a marker for risk stratification of gastroesophageal varices in patients with liver cirrhosis. Radiology 290(1):101–107. https://doi.org/10.1148/radiol.2018180230
Lenz A, Fischer L, Li J, Bannas P (2019) 4D flow MRI for monitoring portal flow in a liver transplant recipient with a renoportal anastomosis. Rofo 191(9):847–848. https://doi.org/10.1055/a-0862-0778
Hyodo R, Takehara Y, Mizuno T, Ichikawa K, Ishizu Y, Sugiyama M, Naganawa S (2021) Time-resolved 3D cine phase-contrast magnetic resonance imaging (4D-flow MRI) can quantitatively assess portosystemic shunt severity and confirm normalization of portal flow after embolization of large portosystemic shunts. Hepatol Res. https://doi.org/10.1111/hepr.13616
Hyodo R, Takehara Y, Mizuno T, Ichikawa K, Ogura Y, Naganawa S (2020) Portal vein stenosis following liver transplantation hemodynamically assessed with 4D-flow MRI before and after portal vein stenting. Magn Reson Med Sci. https://doi.org/10.2463/mrms.ici.2020-0057
Hyodo R, Takehara Y, Mizuno T, Ichikawa K, Yokoyama S, Ishizu Y, Naganawa S (2021) Assessing the complicated venous hemodynamics and therapeutic outcomes of budd-chiari syndrome with respiratory-gated 4D flow MR imaging during the expiratory and inspiratory phases. Magn Reson Med Sci. https://doi.org/10.2463/mrms.ici.2021-0110
Parekh K, Markl M, Rose M, Schnell S, Popescu A, Rigsby CK (2017) 4D flow MR imaging of the portal venous system: a feasibility study in children. Eur Radiol 27(2):832–840. https://doi.org/10.1007/s00330-016-4396-1
Tang Y, Zhang G, Kong W, Yu H, Niu N, Liu J, Liu Y (2021) Pediatric living donor left lateral segment liver transplantation for biliary atresia: Doppler ultrasound findings in early postoperative period. Jpn J Radiol 39(4):367–375. https://doi.org/10.1007/s11604-020-01067-4
Görg C, Riera-Knorrenschild J, Dietrich J (2002) Pictorial review: colour Doppler ultrasound flow patterns in the portal venous system. Br J Radiol 75(899):919–929. https://doi.org/10.1259/bjr.75.899.750919
Abdelaziz O, Attia H (2016) Doppler ultrasonography in living donor liver transplantation recipients: intra- and post-operative vascular complications. World J Gastroenterol 22(27):6145–6172. https://doi.org/10.3748/wjg.v22.i27.6145
Maruyama H, Kato N (2019) Advances in ultrasound diagnosis in chronic liver diseases. Clin Mol Hepatol 25(2):160–167. https://doi.org/10.3350/cmh.2018.1013
Paulson EK, Kliewer MA, Frederick MG, Keogan MT, DeLong DM, Nelson RC (1997) Doppler US measurement of portal venous flow: variability in healthy fasting volunteers. Radiology 202(3):721–724. https://doi.org/10.1148/radiology.202.3.9051024
Yzet T, Bouzerar R, Allart JD, Demuynck F, Legallais C, Robert B, Deramond H, Meyer ME, Baledent O (2010) Hepatic vascular flow measurements by phase contrast MRI and doppler echography: a comparative and reproducibility study. J Magn Reson Imaging 31(3):579–588. https://doi.org/10.1002/jmri.22079
Applegate GR, Thaete FL, Meyers SP, Davis PL, Talagala SL, Recht M, Wozney P, Kanal E (1993) Blood flow in the portal vein: velocity quantitation with phase-contrast MR angiography. Radiology 187(1):253–256. https://doi.org/10.1148/radiology.187.1.8451423
Burkart DJ, Johnson CD, Ehman RL, Weaver AL, Ilstrup DM (1993) Evaluation of portal venous hypertension with cine phase-contrast MR flow measurements: high association of hyperdynamic portal flow with variceal hemorrhage. Radiology 188(3):643–648. https://doi.org/10.1148/radiology.188.3.8351326
Gouya H, Vignaux O, Sogni P, Mallet V, Oudjit A, Pol S, Legmann P (2011) Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients. Radiology 261(1):144–155. https://doi.org/10.1148/radiol.11101541
Gouya H, Grabar S, Vignaux O, Saade A, Pol S, Legmann P, Sogni P (2016) Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging. Eur Radiol 26(7):1981–1990. https://doi.org/10.1007/s00330-015-3991-x
Lee WK, Chang SD, Duddalwar VA, Comin JM, Perera W, Lau WF, Bekhit EK, Hennessy OF (2011) Imaging assessment of congenital and acquired abnormalities of the portal venous system. Radiographics 31(4):905–926. https://doi.org/10.1148/rg.314105104
Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhäll CJ, Ebbers T, Francios CJ, Frydrychowicz A, Geiger J, Giese D, Hope MD, Kilner PJ, Kozerke S, Myerson S, Neubauer S, Wieben O, Markl M (2015) 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson 17(1):72. https://doi.org/10.1186/s12968-015-0174-5
Frydrychowicz A, Roldan-Alzate A, Winslow E, Consigny D, Campo CA, Motosugi U, Johnson KM, Wieben O, Reeder SB (2017) Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension. Eur Radiol 27(12):5316–5324. https://doi.org/10.1007/s00330-017-4862-4
Joseph AA, Voit D, Frahm J (2020) Inferior vena cava revisited - Real-time flow MRI of respiratory maneuvers. NMR Biomed 33(4):e4232. https://doi.org/10.1002/nbm.4232
Ng WH, Chan YL, Sung JY, Lee YT, Lee SF, Chung SS (2004) Comparison of breath-hold 2D phase-contrast with non breath-hold cine phase-contrast MRA in the assessment of azygos venous blood flow in portal hypertension. Magma 16(5):211–217. https://doi.org/10.1007/s10334-003-0026-4
Tsuchiya N, Ayukawa Y, Murayama S (2013) Evaluation of hemodynamic changes by use of phase-contrast MRI for patients with interstitial pneumonia, with special focus on blood flow reduction after breath-holding and bronchopulmonary shunt flow. Jpn J Radiol 31(3):197–203. https://doi.org/10.1007/s11604-012-0171-7
Brunsing RL, Brown D, Almahoud H, Kono Y, Loomba R, Vodkin I, Sirlin CB, Alley MT, Vasanawala SS, Hsiao A (2021) Quantification of the hemodynamic changes of cirrhosis with free-breathing self-navigated MRI. J Magn Reson Imaging 53(5):1410–1421. https://doi.org/10.1002/jmri.27488
Isoda H, Fukuyama A (2022) Quality control for 4D flow MR imaging. Magn Reson Med Sci 21(2):278–292. https://doi.org/10.2463/mrms.rev.2021-0165
Horiguchi R, Takehara Y, Sugiyama M, Hyodo R, Komada T, Matsushima M, Naganawa S, Mizuno T, Sakurai Y, Sugimoto M, Banno H, Komori K, Itatani K (2022) Post-endovascular aneurysmal repair (EVAR) increase in local energy loss for fusiform abdominal aortic aneurysm: assessments with 4D flow MRI. J Magn Reson Imaging accepted for publication
Sidery MB, Macdonald IA, Blackshaw PE (1994) Superior mesenteric artery blood flow and gastric emptying in humans and the differential effects of high fat and high carbohydrate meals. Gut 35(2):186–190. https://doi.org/10.1136/gut.35.2.186
Suzuki K, Takehara Y, Sakata M, Kawate M, Ohishi N, Sugiyama K, Akai T, Suzuki Y, Sugiyama M, Kawamura T, Morita Y, Kikuchi H, Hiramatsu Y, Yamamoto M, Nasu H, Johnson K, Wieben O, Kurachi K, Takeuchi H (2021) Daikenchuto increases blood flow in the superior mesenteric artery in humans: a comparison study between four-dimensional phase-contrast vastly undersampled isotropic projection reconstruction magnetic resonance imaging and Doppler ultrasound. PLoS One 16(1):e0245878. https://doi.org/10.1371/journal.pone.0245878
Berhane H, Scott M, Elbaz M, Jarvis K, McCarthy P, Carr J, Malaisrie C, Avery R, Barker AJ, Robinson JD, Rigsby CK, Markl M (2020) Fully automated 3D aortic segmentation of 4D flow MRI for hemodynamic analysis using deep learning. Magn Reson Med 84(4):2204–2218. https://doi.org/10.1002/mrm.28257
Oyama-Manabe N, Aikawa T, Tsuneta S, Manabe O (2022) Clinical applications of 4D flow MR imaging in aortic valvular and congenital heart disease. Magn Reson Med Sci 21(2):319–326. https://doi.org/10.2463/mrms.rev.2021-0030
Sugiyama M, Takehara Y, Kawate M, Ooishi N, Terada M, Isoda H, Sakahara H, Naganawa S, Johnson KM, Wieben O, Wakayama T, Nozaki A, Kabasawa H (2020) Optimal plane selection for measuring post-prandial blood flow increase within the superior mesenteric artery: analysis using 4D flow and computational fluid dynamics. Magn Reson Med Sci 19(4):366–374. https://doi.org/10.2463/mrms.mp.2019-0089
Sugiyama M, Takehara Y, Naganawa S (2022) Does the pulsatile non-uniform flow matter in MR flowmetry? Magn Reson Med Sci 21(2):365–371. https://doi.org/10.2463/mrms.rev.2021-0099
Jou LD, Lee DH, Morsi H, Mawad ME (2008) Wall shear stress on ruptured and unruptured intracranial aneurysms at the internal carotid artery. AJNR Am J Neuroradiol 29(9):1761–1767. https://doi.org/10.3174/ajnr.A1180
Boussel L, Rayz V, McCulloch C, Martin A, Acevedo-Bolton G, Lawton M, Higashida R, Smith WS, Young WL, Saloner D (2008) Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke 39(11):2997–3002. https://doi.org/10.1161/strokeaha.108.521617
Watanabe T, Isoda H, Fukuyama A, Takahashi M, Amano T, Takehara Y, Oishi N, Kawate M, Terada M, Kosugi T, Komori Y, Fukuma Y, Alley M (2019) Accuracy of the flow velocity and three-directional velocity profile measured with three-dimensional cine phase-contrast MR imaging: verification on scanners from different manufacturers. Magn Reson Med Sci 18(4):265–271. https://doi.org/10.2463/mrms.mp.2018-0063
You S, Masutani EM, Alley MT, Vasanawala SS, Taub PR, Liau J, Roberts AC, Hsiao A (2022) Deep learning automated background phase error correction for abdominopelvic 4D Flow MRI. Radiology 302(3):584–592. https://doi.org/10.1148/radiol.2021211270
Retson TA, Besser AH, Sall S, Golden D, Hsiao A (2019) Machine learning and deep neural networks in thoracic and cardiovascular imaging. J Thorac Imaging 34(3):192–201. https://doi.org/10.1097/rti.0000000000000385
Yzet T, Bouzerar R, Baledent O, Renard C, Lumbala DM, Nguyen-Khac E, Regimbeau JM, Deramond H, Meyer ME (2010) Dynamic measurements of total hepatic blood flow with Phase Contrast MRI. Eur J Radiol 73(1):119–124. https://doi.org/10.1016/j.ejrad.2008.09.032
Tziafalia C, Vlychou M, Tepetes K, Kelekis N, Fezoulidis IV (2006) Echo-Doppler measurements of portal vein and hepatic artery in asymptomatic patients with hepatitis B virus and healthy adults. J Gastrointestin Liver Dis 15(4):343–346
Shi BM, Wang XY, Mu QL, Wu TH, Xu J (2005) Value of portal hemodynamics and hypersplenism in cirrhosis staging. World J Gastroenterol 11(5):708–711. https://doi.org/10.3748/wjg.v11.i5.708
Kayacetin E, Efe D, Doğan C (2004) Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure. J Gastroenterol 39(7):661–667. https://doi.org/10.1007/s00535-003-1362-x
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398(10308):1359–1376. https://doi.org/10.1016/s0140-6736(21)01374-x
Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB (2020) Cirrhotic portal hypertension: from pathophysiology to novel therapeutics. World J Gastroenterol 26(40):6111–6140. https://doi.org/10.3748/wjg.v26.i40.6111
Bhathal PS, Grossman HJ (1985) Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1(4):325–337. https://doi.org/10.1016/s0168-8278(85)80770-4
Møller S, Hobolth L, Winkler C, Bendtsen F, Christensen E (2011) Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut 60(9):1254–1259. https://doi.org/10.1136/gut.2010.235473
Zardi EM, Dobrina A, Uwechie V, Cacciapaglia F, Rollo M, Laghi V, Ambrosino G, Lumachi F (2008) Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome. In Vivo 22(4):509–512
Koh TS, Thng CH, Hartono S, Choo SP, Ng QS, Khoo JB, Bisdas S, Koh DM (2011) Deconvolution assessment of splenic and splanchnic contributions to portal venous blood flow in liver cirrhosis. Med Phys 38(5):2768–2782. https://doi.org/10.1118/1.3582691
Schiedermaier P, Koch L, Mojón A, Hermida R, Layer G, Sauerbruch T (2006) Circadian rhythm of fasting and postprandial portal blood flow in cirrhosis. Scand J Gastroenterol 41(7):826–832. https://doi.org/10.1080/00365520500463290
de Vries PJ, de Hooge P, Hoekstra JB, van Hattum J (1994) Blunted postprandial reaction of portal venous flow in chronic liver disease, assessed with duplex Doppler: significance for prognosis. J Hepatol 21(6):966–973. https://doi.org/10.1016/s0168-8278(05)80603-8
Gaiani S, Bolondi L, Li Bassi S, Santi V, Zironi G, Barbara L (1989) Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology 9(6):815–819. https://doi.org/10.1002/hep.1840090604
Roldán-Alzate A, Campo CA, Mao L, Said A, Wieben O, Reeder SB (2022) Characterization of mesenteric and portal hemodynamics using 4D flow MRI: the effects of meals and diurnal variation. Abdom Radiol (NY). https://doi.org/10.1007/s00261-022-03513-5
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J (2017) Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 65(1):310–335. https://doi.org/10.1002/hep.28906
Bloom S, Kemp W, Lubel J (2015) Portal hypertension: pathophysiology, diagnosis and management. Intern Med J 45(1):16–26. https://doi.org/10.1111/imj.12590
Ishizu Y, Ishigami M, Honda T, Kuzuya T, Ito T, Komada T, Fujishiro M (2021) Simplification of balloon-occluded retrograde transcatheter obliteration procedure using a coaxial double balloon catheter compared with a single-balloon catheter. Jpn J Radiol 39(3):296–302. https://doi.org/10.1007/s11604-020-01060-x
Villanueva C, Aracil C, Colomo A, Lopez-Balaguer JM, Piqueras M, Gonzalez B, Torras X, Guarner C, Balanzo J (2009) Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Aliment Pharmacol Ther 29(4):397–408. https://doi.org/10.1111/j.1365-2036.2008.03880.x
D’Amico G, Garcia-Pagan JC, Luca A, Bosch J (2006) Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131(5):1611–1624. https://doi.org/10.1053/j.gastro.2006.09.013
Groszmann RJ, Wongcharatrawee S (2004) The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39(2):280–282. https://doi.org/10.1002/hep.20062
Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC (1998) Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. Qjm 91(1):19–25. https://doi.org/10.1093/qjmed/91.1.19
Procopet B, Berzigotti A (2017) Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) 5(2):79–89. https://doi.org/10.1093/gastro/gox012
Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB (2021) North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2021.07.018
Miraglia R, Maruzzelli L, Cannataci C, Gerasia R, Mamone G, Cortis K, Cimò B, Petridis I, Volpes R, Luca A (2020) Radiation exposure during transjugular intrahepatic portosystemic shunt creation in patients with complete portal vein thrombosis or portal cavernoma. Radiol Med 125(7):609–617. https://doi.org/10.1007/s11547-020-01155-5
Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell’Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC (2019) Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology 69(1):282–293. https://doi.org/10.1002/hep.30182
Fonio P, Discalzi A, Calandri M, Doriguzzi Breatta A, Bergamasco L, Martini S, Ottobrelli A, Righi D, Gandini G (2017) Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification. Radiol Med 122(9):713–721. https://doi.org/10.1007/s11547-017-0770-6
Carr CE, Tuite CM, Soulen MC, Shlansky-Goldberg RD, Clark TW, Mondschein JI, Kwak A, Patel AA, Coleman BG, Trerotola SO (2006) Role of ultrasound surveillance of transjugular intrahepatic portosystemic shunts in the covered stent era. J Vasc Interv Radiol 17(8):1297–1305. https://doi.org/10.1097/01.Rvi.0000231951.47931.82
Pinter SZ, Rubin JM, Kripfgans OD, Novelli PM, Vargas-Vila M, Hall AL, Fowlkes JB (2015) Volumetric blood flow in transjugular intrahepatic portosystemic shunt revision using 3-dimensional Doppler sonography. J Ultrasound Med 34(2):257–266. https://doi.org/10.7863/ultra.34.2.257
Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2):715–735. https://doi.org/10.1002/hep.27210
Lynn AM, Singh S, Congly SE, Khemani D, Johnson DH, Wiesner RH, Kamath PS, Andrews JC, Leise MD (2016) Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy. Liver Transpl 22(6):723–731. https://doi.org/10.1002/lt.24440
Kako Y, Yamakado K, Jomoto W, Nasada T, Asada K, Takaki H, Kobayashi K, Daimon T, Hirota S (2017) Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt. Jpn J Radiol 35(7):366–372. https://doi.org/10.1007/s11604-017-0647-6
Naeshiro N, Kakizawa H, Aikata H, Kan H, Fujino H, Fukuhara T, Kobayashi T, Honda Y, Miyaki D, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Ishikawa M, Awai K, Chayama K (2014) Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: long-term outcomes in 14 patients. Hepatol Res 44(7):740–749. https://doi.org/10.1111/hepr.12181
Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, Garcia-Pagan JC, Barrufet M, Jalan R, Brookes J, Thalassinos E, Burroughs AK, Cordoba J, Nevens F (2013) Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 57(6):2448–2457. https://doi.org/10.1002/hep.26314
Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC (2021) Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases. Hepatology 73(1):366–413. https://doi.org/10.1002/hep.31646
Masuda Y, Yoshizawa K, Ohno Y, Mita A, Shimizu A, Soejima Y (2020) Small-for-size syndrome in liver transplantation: definition, pathophysiology and management. Hepatobiliary Pancreat Dis Int 19(4):334–341. https://doi.org/10.1016/j.hbpd.2020.06.015
Miller CM, Quintini C, Dhawan A, Durand F, Heimbach JK, Kim-Schluger HL, Kyrana E, Lee SG, Lerut J, Lo CM, Pomfret EA (2017) The international liver transplantation society living donor liver transplant recipient guideline. Transplantation 101(5):938–944. https://doi.org/10.1097/tp.0000000000001571
Monti L, Soglia G, Tomà P (2016) Imaging in pediatric liver transplantation. Radiol Med 121(5):378–390. https://doi.org/10.1007/s11547-016-0628-3
Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K (1999) Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 67(2):321–327. https://doi.org/10.1097/00007890-199901270-00024
Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE, Gillespie BW, Everhart JE (2015) Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl 21(1):79–88. https://doi.org/10.1002/lt.23966
Ikeda O, Tamura Y, Nakasone Y, Yamashita Y, Okajima H, Asonuma K, Inomata Y (2010) Percutaneous transluminal venoplasty after venous pressure measurement in patients with hepatic venous outflow obstruction after living donor liver transplantation. Jpn J Radiol 28(7):520–526. https://doi.org/10.1007/s11604-010-0463-8
Copelan A, Remer EM, Sands M, Nghiem H, Kapoor B (2015) Diagnosis and management of Budd Chiari syndrome: an update. Cardiovasc Intervent Radiol 38(1):1–12. https://doi.org/10.1007/s00270-014-0919-9
Bansal V, Gupta P, Sinha S, Dhaka N, Kalra N, Vijayvergiya R, Dutta U, Kochhar R (2018) Budd-Chiari syndrome: imaging review. Br J Radiol 91(1092):20180441. https://doi.org/10.1259/bjr.20180441
Chen ZK, Fan J, Cao C, Li Y (2018) Endovascular treatment for hepatic vein-type Budd-Chiari syndrome: effectiveness and long-term outcome. Radiol Med 123(10):799–807. https://doi.org/10.1007/s11547-018-0907-2
Corso R, Intotero M, Solcia M, Castoldi MC, Rampoldi A (2008) Treatment of Budd-Chiari syndrome with transjugular intrahepatic portosystemic shunt (TIPS). Radiol Med 113(5):727–738. https://doi.org/10.1007/s11547-008-0288-z
Nakaza M, Matsumoto M, Sekine T, Inoue T, Ando T, Ogawa M, Obara M, Leonowicz O, Kumita S, Usuda J (2021) Dual-VENC 4D flow MRI can detect abnormal blood flow in the left atrium that potentially causes thrombosis formation after left upper lobectomy. Magn Reson Med Sci. https://doi.org/10.2463/mrms.mp.2020-0170
Isorni MA, Moisson L, Moussa NB, Monnot S, Raimondi F, Roussin R, Boet A, van Aerschot I, Fournier E, Cohen S, Kara M, Hascoet S (2020) 4D flow cardiac magnetic resonance in children and adults with congenital heart disease: clinical experience in a high volume center. Int J Cardiol 320:168–177. https://doi.org/10.1016/j.ijcard.2020.07.021
Hirtler D, Garcia J, Barker AJ, Geiger J (2016) Assessment of intracardiac flow and vorticity in the right heart of patients after repair of tetralogy of Fallot by flow-sensitive 4D MRI. Eur Radiol 26(10):3598–3607. https://doi.org/10.1007/s00330-015-4186-1
Funding
The second author YT is an endowed chair of the department financially supported by a private company HN; however, the status is not relevant to the contents of this paper. Other authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Contributions
Material preparation, article collection, and evaluation were performed by RH and YT. The first draft of the manuscript was written by RH and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interests
The authors have no relevant financial or non-financial interests to disclose
Ethical approval
This paper was based in line with the principles of the Declaration of Helsinki. With respect to the MR imaging in the paper, approval was granted by the Ethics Committee of Nagoya University (No. 2018-0469).
Consent to participate
Informed consent was obtained from all individual participants included in the paper.
Consent to publish
The authors affirm that human research participants provided informed consent for publication of the images in figures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 13780 KB)
Supplementary file2 (MP4 2141 KB)
Supplementary file3 (MP4 1352 KB)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hyodo, R., Takehara, Y. & Naganawa, S. 4D Flow MRI in the portal venous system: imaging and analysis methods, and clinical applications. Radiol med 127, 1181–1198 (2022). https://doi.org/10.1007/s11547-022-01553-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-022-01553-x